Bromide

Bromide

SCHEMBL5437785

Br.Cc1cccc(C)n1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771685 0.96 CCR1 (0.71)
SCHEMBL30421349 0.96
SCHEMBL9611 0.96
SCHEMBL30898550 0.93
SCHEMBL17822110 0.93
Iodide SCHEMBL8148528 0.93
Hydrogen Sulfide SCHEMBL20214420 0.93
Ammonia Solution, Strong SCHEMBL18983640 0.93
Fluoride SCHEMBL38652089 0.93
SCHEMBL184761 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153701-A1 PROCESS FOR PREPARING 4-AMINO-5-METHYLPYRIDONE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-05-19 US claimed
US-20220153701-A1 PROCESS FOR PREPARING 4-AMINO-5-METHYLPYRIDONE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-05-19 US disclosed
US-20070249639-A1 Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives BAENTELI ROLF 2007-10-25 US disclosed
EP-1734968-A2 USE OF 9H-PURINE-2,6-DIAMINE DERIVATIVES IN THE TREATMENT OF PROLIFERATIVE DISEASES AND NOVEL 9H-PURINE-2,6-DIAMINE DERIVATIVES Novartis AG (CH) 2006-12-27 EP disclosed
WO-2005097135-A2 USE OF 9H-PURINE-2,6-DIAMINE DERIVATIVES IN THE TREATMENT OF PROLIFERATIVE DISEASES AND NOVEL 9H-PURINE-2,6-DIAMINE DERIVATIVES NOVARTIS AG (CH) 2005-10-20 WO disclosed
EP-0135304-B1 PREPARATION OF SUBSTITUTED BENZAMIDES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-03-14 EP disclosed
US-4786747-A BROMINATION IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-11-22 US disclosed
US-4575557-A ACETONITRILE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-03-11 US disclosed
EP-0135304-A2 Preparation of substituted benzamides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-03-27 EP disclosed